Distinct antiviral resistance profiles for three authentic HIV integrase inhibitors L-708,906, S-1360 and V-165

Fikkert; Bénédicte Van Maele; Barbara Van Remoortel; Martine Michiels; Jo Vercammen; Christophe Pannecouque; Yves Engelborghs; De Clercq Erik; Zeger Debyser; Myriam Witvrouw

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2001

Selection of antiviral resistance against diketo derivatives, authentic inhibitors of HIV-1 integration

Myriam Witvrouw, Wim Pluymers, Nouri Neamati, Terrence R. Burke, Godwin C. G. Pais, De Clercq Erik, Christophe Pannecouque, Zeger Debyser

Article2005

The V165I and T206S/S230N mutations in Human Immunodeficiency Virus-1 integrase confer resistance to the pyranodipyrimidine V-165 and reduce replication capacity

Myriam Witvrouw, Anke Hantson, Anneleen Hombrouck, Jo Vercammen, Tetz, Christophe Pannecouque, Yves Engelborghs, De Clercq Erik, Zeger Debyser

Article2002

Antiviral resistance to diketo acids is associated with the mutations T66I, L74M and S230R in the HIV-1 integrase gene

Myriam Witvrouw, Valery Fikkert, Bénédicte Van Maele, Christophe Pannecouque, Nouri Neamati, Terrence R. Burke, Godwin C. G. Pais, De Clercq Erik, Zeger Debyser

Article2025

Development of enhanced HIV-1 non-nucleoside reverse transcriptase inhibitors with improved resistance and pharmacokinetic profiles

Zhao Wang, Shawn Rumrill, Dongwei Kang, Samuel Desta Guma, Da Feng, De Clercq Erik, Christophe Pannecouque, Chin‐Ho Chen, Eddy Arnold, Francesc X. Ruiz, Xinyong Liu, Peng Zhan

Article1982

ChemInform Abstract: STUDIES ON S‐ADENOSYL‐L‐HOMOCYSTEINE HYDROLASE. PART V. SYNTHESIS AND ANTIVIRAL ACTIVITY OF STEREOISOMERIC ERITADENINES

A. HOLY, Ivan Votruba, De Clercq Erik